Cargando…

Epidemiology of Vitiligo – A Dual Population-Based Approach

BACKGROUND: Most epidemiological data on vitiligo refer to selected environments or focus on the prevalence of comorbidity unrelated to the population. OBJECTIVE: Aim of the study was to gain robust representative prevalence data on vitiligo and on associated dermatologic comorbidity in the German a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr, Nicole, Petersen, Jana, Kirsten, Natalia, Augustin, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165096/
https://www.ncbi.nlm.nih.gov/pubmed/34079380
http://dx.doi.org/10.2147/CLEP.S304155
_version_ 1783701241344294912
author Mohr, Nicole
Petersen, Jana
Kirsten, Natalia
Augustin, Matthias
author_facet Mohr, Nicole
Petersen, Jana
Kirsten, Natalia
Augustin, Matthias
author_sort Mohr, Nicole
collection PubMed
description BACKGROUND: Most epidemiological data on vitiligo refer to selected environments or focus on the prevalence of comorbidity unrelated to the population. OBJECTIVE: Aim of the study was to gain robust representative prevalence data on vitiligo and on associated dermatologic comorbidity in the German adult population. METHODS: A dual population-based approach was applied with 1) primary data obtained between 2004 and 2014 from dermatological exams in the general working population; 2) claims data from a large German statutory health insurance, reference year 2010. RESULTS: In the working cohort (N = 121,783; 57% male; mean age 43 years), the prevalence of vitiligo was 0.77% (0.84% in men; 0.67% in women). In the claims data (N = 1,619,678; 38% male; mean age 46 years), prevalence was 0.17% (0.14% in men; 0.18% in women). In the working cohort, vitiligo was significantly more common in people with fair skin type, ephelides and port-wine stains and less common in people with acne and solar lentigines. In the claims data, vitiligo was associated with a variety of skin conditions, eg, atopic dermatitis, psoriasis and alopecia areata. CONCLUSION: The resulting discrepancy of claims vs primary data between 0.17% and 0.77% indicates the most probable spectrum of vitiligo prevalence in Germany. It is more frequently observed in clinical exams than recorded in claims data, indicating a marked proportion of people seeking no medical help. Such nonattendance may result from the fact that many treatment options do not provide satisfying benefits to the patients.
format Online
Article
Text
id pubmed-8165096
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81650962021-06-01 Epidemiology of Vitiligo – A Dual Population-Based Approach Mohr, Nicole Petersen, Jana Kirsten, Natalia Augustin, Matthias Clin Epidemiol Original Research BACKGROUND: Most epidemiological data on vitiligo refer to selected environments or focus on the prevalence of comorbidity unrelated to the population. OBJECTIVE: Aim of the study was to gain robust representative prevalence data on vitiligo and on associated dermatologic comorbidity in the German adult population. METHODS: A dual population-based approach was applied with 1) primary data obtained between 2004 and 2014 from dermatological exams in the general working population; 2) claims data from a large German statutory health insurance, reference year 2010. RESULTS: In the working cohort (N = 121,783; 57% male; mean age 43 years), the prevalence of vitiligo was 0.77% (0.84% in men; 0.67% in women). In the claims data (N = 1,619,678; 38% male; mean age 46 years), prevalence was 0.17% (0.14% in men; 0.18% in women). In the working cohort, vitiligo was significantly more common in people with fair skin type, ephelides and port-wine stains and less common in people with acne and solar lentigines. In the claims data, vitiligo was associated with a variety of skin conditions, eg, atopic dermatitis, psoriasis and alopecia areata. CONCLUSION: The resulting discrepancy of claims vs primary data between 0.17% and 0.77% indicates the most probable spectrum of vitiligo prevalence in Germany. It is more frequently observed in clinical exams than recorded in claims data, indicating a marked proportion of people seeking no medical help. Such nonattendance may result from the fact that many treatment options do not provide satisfying benefits to the patients. Dove 2021-05-26 /pmc/articles/PMC8165096/ /pubmed/34079380 http://dx.doi.org/10.2147/CLEP.S304155 Text en © 2021 Mohr et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mohr, Nicole
Petersen, Jana
Kirsten, Natalia
Augustin, Matthias
Epidemiology of Vitiligo – A Dual Population-Based Approach
title Epidemiology of Vitiligo – A Dual Population-Based Approach
title_full Epidemiology of Vitiligo – A Dual Population-Based Approach
title_fullStr Epidemiology of Vitiligo – A Dual Population-Based Approach
title_full_unstemmed Epidemiology of Vitiligo – A Dual Population-Based Approach
title_short Epidemiology of Vitiligo – A Dual Population-Based Approach
title_sort epidemiology of vitiligo – a dual population-based approach
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165096/
https://www.ncbi.nlm.nih.gov/pubmed/34079380
http://dx.doi.org/10.2147/CLEP.S304155
work_keys_str_mv AT mohrnicole epidemiologyofvitiligoadualpopulationbasedapproach
AT petersenjana epidemiologyofvitiligoadualpopulationbasedapproach
AT kirstennatalia epidemiologyofvitiligoadualpopulationbasedapproach
AT augustinmatthias epidemiologyofvitiligoadualpopulationbasedapproach